In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

B-Cell Directed Therapies for Autoimmune Diseases Virtual Summit

Oct 14, 2021 - 09:00 AM - Oct 15, 04:30 PM
Hanson Wade

ZIP: 00000

Ticket Price: USD 1499.00 to USD 2099.00

Several clinical trials of B and plasma cell directed therapies are demonstrating posi-tive results across a broad range of non-oncological, immune mediated diseases including systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and Sjogren's syndrome. However, the vast potential of developing next generation B cell directed therapies remains challenging with limited fundamental knowledge on the role of B and plasma cell subtypes in health, autoimmunity and the wider immune system.

Our virtual summit arrives as the first ever cross-disciplinary meeting for large pharma, biotech and academia. This forum is dedicated to harnessing the full therapeutic opportunity of numerous candidates directed against various B and plasma cell targets (incl. CD20, PI3K, BTK and more). Come armed with questions, ideas and ex-periences and together, take steps to develop the next generation of B cell directed therapies to improve immune mediated disease management, define effective combination treatment regimens and transform patient outcomes.

Industry Pricing: USD 1799.00,
Standard Pricing: USD 2099.00,
Academic Pricing: USD 1499.00

Brochure: https://go.evvnt.com/657323-0?pid=1052
Tickets: https://go.evvnt.com/657323-2?pid=1052


Speaker Details

Aimee Payne, Professor and Co-Founder of Cabaletta BioUniversity of Pennsylvania, Paul Smith, Senior Director - Pharmacology (Non-Oncology), Incyte Corporation, Amit Choudhury, Principal Scientist: M267 CD38 SIFbody Program Co-Lead, Momenta Pharmaceuticals, Gregory Wu, Associate Professor of Neurology, Washington University in St. Louis, School of Medicine, Jessica Kenison-White, Senior Scientist, AnTolRx, Inc., Claire Langrish, Vice President - Immunology and Biology, Principia Biopharma, Thomas Tedder, Alter Geller Distinguished Professor for Research in Immunology, Duke University School of Medicine, Martin Kaul, Executive Director Translational Medicine, Autoimmunity, Novartis Institutes for Biomedical Research, Michaël Mingueneau, Associate Director, Multiple Sclerosis Research Unit, Biogen, and more!

Event Categories
Keywords: Health , Medicine , science , Conferences


Events Calendar

26 27 28 29 30 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6


VIP Life Time Subscription to our Newsletters!